In the midst of the Coronavirus Crash, there have been several small-cap companies that have experienced a surge in attention and in their stock's share price. Many of these tickers are healthcare companies that are attempting to develop vaccines, antivirals, devices, or therapeutics to combat COVID-19. Luckily, I have positions in several of these companies and my speculative portfolio has performed very well during this volatility. Unfortunately, not all of these companies are going to be successful in producing a viable product, or they will be a laggard in the race to be the first-to-market